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Abstract
Background: Microarray data sets provide relative expression levels for thousands of
genes for a small number, in comparison, of different experimental conditions called
assays. Data mining techniques are used to extract specific information of genes as
they relate to the assays. The multivariate statistical technique of principal
component analysis (PCA) has proven useful in providing effective data mining
methods. This article extends the PCA approach of Rollins et al. to the development
of ranking genes of microarray data sets that express most differently between two
biologically different grouping of assays. This method is evaluated on real and
simulated data and compared to a current approach on the basis of false discovery
rate (FDR) and statistical power (SP) which is the ability to correctly identify
important genes.
Results: This work developed and evaluated two new test statistics based on PCA
and compared them to a popular method that is not PCA based. Both test statistics
were found to be effective as evaluated in three case studies: (i) exposing E. coli cells
to two different ethanol levels; (ii) application of myostatin to two groups of mice;
and (iii) a simulated data study derived from the properties of (ii). The proposed
method (PM) effectively identified critical genes in these studies based on
comparison with the current method (CM). The simulation study supports higher
identification accuracy for PM over CM for both proposed test statistics when the
gene variance is constant and for one of the test statistics when the gene variance is
non-constant.
Conclusions: PM compares quite favorably to CM in terms of lower FDR and much
higher SP. Thus, PM can be quite effective in producing accurate signatures from
large microarray data sets for differential expression between assays groups identified
in a preliminary step of the PCA procedure and is, therefore, recommended for use
in these applications.
Introduction
It is well known that living organisms have complicated gene structures. However,
while major advancements have been made in recent years, understanding of the biolo-
gical functions of each individual gene is still quite limited. Active research is strongly
focused on understanding the behavior of genes and as well as the highly complex
metabolism and regulatory network inside living cells [1]. This effort falls under a
molecular biological field called functional genomics (FG). There are at least three
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reproduction in any medium, provided the original work is properly cited.areas in which experimental techniques are widely applied in FG: transcriptomics, pro-
teomics, and metabolomics [2]. A combination of leading scientific techniques as well
as powerful mathematical and statistical tools for data analysis makes the task of iden-
tifying important transcriptome, proteome, and metabolome corresponding to a biolo-
gical effect promising. Typical studies in these areas involve the identification of
possible behavior and responses of species under various genetic backgrounds as well
as environmental factors (i.e. assay).
There are different high technology techniques applied in FG field to advance under-
standing of the transcriptional genetic response of many organisms in various environ-
mental perturbations [1]. One of the techniques that have been adopted in this field is
a multiplex technology called DNA microarray [3]. A new technique that is becoming
popular and will probably displace array-based measurement in FG is next-generation
sequencing (RNAseq) [4,5]. These techniques have the ability to generate data sets that
consist of expression levels of thousands of genes, providing a wealth of information
that is hidden by high noise levels, low signal levels, and a relatively small number of
experimental units to the number of genes studied. More specifically, since the data
set containing the gene expression measurements consists of a lot more genes than
assays, analytical techniques are needed to provide accurate gene identification under a
large number of gene candidates that is much greater than the number of experimental
runs.
To achieve this objective, traditional statistical methods, such as principal component
analysis (PCA) [2-8], the focus of this article, are being retrofitted to provide effective
statistical inference in this challenging context of microarray data analysis. Other
methods used in this field included linear model analysis [9-14], Bayesian method
[15-17] and network component analysis (NCA) [18-20]. Thus, statistics is playing a
critical role through the development of methodologies that give high statistical power
(SP) (i.e., accurate identification), and low false discovery rate (FDR)[21] (i.e. low misi-
dentification). To this end, this article introduces two new PCA based statistics for
determining gene rank for differential expression between two PCA identified assay
groups. This work extends the technique introduced by Rollins et al.[2] that deter-
mines gene rank for a single PCA identified assay group. Thus, the proposed method
(PM) in this work is aimed at finding the genes with high expression levels in one
group and low expression levels in the other group.
The PM uses PCA to first establish the existence of the assay groupings of interest.
Then using the results that established the grouping, the differential contribution for
each gene is determined using a statistic based on eigenvalues. This article proposes
and evaluates two statistics. The first one is the group averaged difference of eigenva-
lue linear combinations that we call Tdiff. The second one divides Tdiff by its estimated
pooled standard deviation that we call Tscaled. The genes are ranked based on the lar-
gest absolute value of these statistics. The PM is evaluated against the ranking deter-
mined by the well known Student’s t-statistic [14] that we call Tpooled in this work. We
will refer to Tpooled as the current method (CM) which is actually a subclass of the PM
that weighs each assay equally in each group. Note that for the CM the assay members
in each group is not established based on the data but by á priori considerations. In
contrast, for the PM the data drives the assay weight as well as group assignment of
the assays.
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effectiveness (i.e., power) in identifying assay-specific signature: (i) exposure of E. coli
cells to two different levels of ethanol concentration [22]; (ii) the use of myostatin as
inhibitor of skeletal muscle growth for five 5-weeks-old myostatin and non-treated
mice [10]; and (iii) a simulation study based on statistical properties of the second case
study.
This work is organized into the following sections. The Background Section gives a
brief review of PCA and connects it to our application in FG’s data analysis. This sec-
tion is followed by the Methods Section that derives and presents the test statistics of
the CM and PM. These test statistics are evaluated and compared in three studies in
the Results and Discussion Section. The final section summarizes the results and gives
concluding remarks on the contribution of this work.
Background
T h em i c r o a r r a yd a t as e ti sg i v e na sa nm by n matrix X where n is the number of
assays expressed along columns (i.e. variables) and m represents the number of genes
expressed along rows. The cells in this matrix are given as xij which is the expression
level of the i
th gene for the j
th assay (i.e. condition). Principal component analysis
(PCA) is a multivariate technique that mathematically transforms (rotates) the original
coordinate system to a new orthogonal coordinate system based on correlations among
the variables [23]. The principal components (PCs) are eigenvectors generated from
either the covariance matrix (scaled sum of squares and cross products) or the correla-
tion matrix (sums of squares and cross products from standardized data) of the vari-
ables involved. They are used to construct n linear combinations of the n variables
that can be thought of as n pseudo variables [23]. A PC is rank ordered by the amount
of variation in the original data set that it captures.
An illustration is given in Figure 1 that shows a visual representation of a two-
dimensional data system (x) and a rotated data system (z). As shown, the new coordi-
nated system points z1 in the direction with the greatest spread in the data. The other
variable, z2,p o i n t si nad i r e c t i o nt h a ti so r t h o g o n a lt oz1, but also seeks to maximize
spread in this direction. The first PC determines z1 and the second PC determines z2.
A data matrix of rank n will give n PCs that are linear combinations of the variables in
Figure 1 Visual representation of the original data system and the rotated data system.T h ef i g u r e
represents the original data system on the horizontal and vertical axis while the new rotated data system
is represented as z1 and z2. Variance-covariance matrices for original data system and rotated data system
are shown on the right of the figure.
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application of PCA is to obtain at least one pseudo variable that represent the biologi-
cal behavior of interest. This can be a PC that represents a small portion of the total
variation making it a potentially very powerful data mining approach.
The top of Figure 2 shows the relationship between the original data matrix, X, the n
by n PC loading matrix, L,a n dt h em by n pseudo data matrix, called the scores
matrix, S. The PCs derived from X are called eigengenes (EG) because the elements of
S represent pseudo values for gene expression. In Figure 2 the bottom set of matrices
are derived from the transpose of X which is an n by m matrix. In this case the loading
matrix is m by n in dimension and the scores matrix is n by n in dimension. The PCs
derived from the transpose of X are called eigenassays (EA) because the elements of
the scores matrix represent pseudo assays. The proposed method (PM), following Roll-
ins et al. [2], uses both EG and EA approaches to develop signatures sets of ranked
genes. In the next section we derive the EG and EA statistics for determining gene
contribution for the PM.
Methods
Eigengene Contribution Approach
The first step in the eigengene (EG) approach of the PM is to standardized the ele-
ments of X to give the standardized matrix Z with each element equal to
x j ,w h e r e x j and sj are the sample mean and sample standard deviation of the data
Figure 2 Visual representation of data, loading, and score matrices for X and X
T. The upper part of
this figure represents the EG procedure while the bottom part of this figure represents the EA procedure.
Note that dimension of the data matrix used for EG and EA and different.
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plicity and are taken as the scope of this work:
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where sij
EG is the score for the i
th gene using the j
th vector of EG loadings, ij
EG is the
i
th loading for the j
th EG vector, and gijk
EG is the contribution for the i
th gene, on the k
th
assay from the j
th EG loading vector. Let A = Group A with nA assay members and B =
Group B with nB assay members with no members in common with Group A such that
2 ≤+≤ nnn AB (2)
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th EG loading vector for Groups A and
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where k’ and k’’ are the assay members in Groups A and B, respectively. Finally, the
EG differential gene contribution between Groups A and B for the i
th gene from the
j
th EG loading vector is given as
dg g g ij
EG
ij
EG
ij
EG AB =− (5)
T h eb a s i cd i f f e r e n c eb e t w e e nt h em e t h o di n Rollins et al. [2] and this extension is
that work developed gene signatures for individual groups using equations of the form
given by (3) and (4) and this work uses equation of the form given by Eq. 5.
Eigenassay Contribution Approach
As stated above, the EA approach uses the transpose of X as the data matrix treating
the genes as the variables. Following Rollins et al. [2], X
T is not standardized in the EA
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EA,a r ed e t e r m i n e d
from Eq. 6 as follows:
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where sij
EG is the score for the i
th assay using the j
th vector of EA loadings, ij
EG is
the i
th loading for the j
th EA vector, and gijp
EA is the contribution for the p
th gene, on
the i
th assay from the j
th EA loading vector. As above, for A = Group A with nA assay
members and B = Group B with nB assay members with no members in common with
Group A, we obtain the contribution expressions as follows. The mean contribution
for p
th gene from the j
th EA loading vector for Groups A and B are
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respectively, where i’ and i” represent the assay members in Groups A and B, respec-
tively. Finally, the EA differential gene contribution between Groups A and B for the
p
th gene from the j
th EG loading vector is given as
dg g g jp
EA
jp
EA
jp
EA AB =− (9)
Test Statistics
The next step after deriving the gene contribution equations is to define the decision
or test statistics based on these derivations. Tdiff for EG and EA are equivalent to Eqs.
5 and 9, respectively. More specifically,
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loadings as fixed variables (making these expressions approximations):
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Thus, combining Eqs. 10-11, the variances for Tdiff
EG
ij and Tdiff
EA
jp respectively are:
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estimated standard deviation using Eq. 16:
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2 and sBzi
2 are the sample variances for the standardized expression levels
for Groups A and B, respectively, corresponding to the i
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Similarly, the scaled test statistic in the EA case can also be given now by dividing
Eq. 11 by the estimated standard deviation using Eq. 17:
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sAxp
2 and sBxp
2 are the sample variances for the un-standardized expression levels for
Groups A and B, respectively, corresponding to the p
th gene. Note that Tscale
EA
JP is inde-
pendent PCA loadings and thus, does not benefit from PCA. In actuality, Eq. 21 is the
commonly known Student’s t-statistics [14]; thus,
TT pooled p scale
EA
JP , = (23)
From Eq. 23 it is clear that scaling the EA differential contribution is not providing
any new technique in PCA and therefore is not a useful result under the PM. Thus,
we do not propose scaling for the EA approach.
The steps for applying the PM are as follows:
1. Standardize X to obtain Z.
2. Obtain the loading and scores matrices for X (EG) based on correlation.
3. Obtain the loading and scores matrices for X
T (EA) based on covariance.
4. For each of the n EG loading vectors, plot its loadings against the assay number.
Select the plot(s) that separate the assays into desired or interesting groups for
further analysis.
5. For each n EA score vectors, plot its scores against the assay number. Select the
plot(s) that separate the assays into desired or interesting groups for further
analysis.
6. For each selected EG loading vector in Step 4, using Z and Eq. 5 determine the
differential EG contribution for each gene.
7. For each selected EA loading vector in Step 5, using X and Eq. 9 determine the
differential EA contribution for each gene.
8. For each case in Steps 6 and 7, rank order the differential contribution and then
table (with the corresponding gene) and plot these values against the rank. These
signature plots can be used to determine where to make cutoffs as described in
Rollins et al. [2].
In the next section we evaluate the proposed test statistics that we have derived in
this section against a current method that uses the Student’s t-test statistic. This work
also includes an evaluation to determine when it is better to choose Tdiff or Tscale.
Results and Discussion
The best choice for a test statistics is the one that has the highest statistical power (SP)
and the lowest false discovery rate (FDR) [21]. This section presents three case studies
to evaluate the proposed test statistics against one another and against a current
method (CM) that uses Tpooled. The first study revisits the single group analysis in Roll-
ins et al. [2] involving exposure of E. coli cells to two different levels of ethanol con-
centration [2,22]. The second study applies the proposed method (PM) to data from
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letal muscle growth for five 5-weeks-old myostatin (called “mutant”) and non-treated
(called “wild-type”) mice in each group. The third study is a mathematically simulated
data study using characteristics of the data from Study 2.
Exposure of E. coli cells Study
The data set for the first case study contains E. coli cells that were exposed to two dif-
ferent ethanol concentrations. In Rollins et al.[2] ranked signatures were obtained for
non-ethanol (i.e., non-treated) (Group A) and ethanol (Group B) separately. Thus,
these signatures ranked the genes based on their contribution to the score of their
group. However, the goal of this work is to obtain a ranked signature of the genes that
is based on the difference of gene contribution between the two groups. Therefore,
under this objective, genes with high contribution in both groups would not be ranked
high; whereas, genes with low contribution in one group and high contribution in the
other group could be ranked high based on the greatest negative, positive, or absolute
difference, depending on the interests of the experimenter. For this study, we ranked
the genes based on absolute difference for evaluative purposes.
The results of this study using the PM ar eg i v e ni nT a b l e1a n dF i g u r e3 .T h e s e
results were obtained from the first PC for an EA analysis (since it indicated the stron-
gest separation) using Tdiff
EA
i1 only to determine differential gene contribution. This PC
was selected, as supported by Figure 3, because it separated the two groups in the
score plot quite well. The plot on the right in Figure 3 gives the differential contribu-
tion calculated from Tdiff
EA
i1 by rank with the rank decreasing with increasing value on
the horizontal axis. As this figure shows, the top genes clearly standout by their dis-
tinct separation and how they line up almost vertically along the vertical axis. Table 1
gives the top 20 genes that expressed the most differently between ethanol treated and
non-ethanol treated groups. This list contains some of the top genes in the ethanol
and non-ethanol signatures in Rollins et al.[2] as indicated. In addition, it contains
genes that were not ranked very high in either signature. However, note that each gene
is at opposite ends of the signatures in Rollins et al.[2] in support of their differential
significance. Thus, the PM has potentially found genes that might express relatively
low within assays of similar conditions but quite differently between assays of different
Table 1 Top 20 genes that showed distinct difference between ethanol and non-ethanol
along with their ranking
Rank Gene Name EtOH Rank* Non-EtOH Rank* Rank Gene Name EtOH Rank* Non-EtOH Rank*
1 b2387 729 2001 11 argT 925 2330
2 ybdO 558 2182 12 argH 2 4286
3 b1455 959 2120 13 ycbE 317 3626
4 gltD 2884 151 14 b0538 328 2658
5 appY 360 2457 15 citB 372 2642
6 caiA 5 3810 16 wbbH 2952 408
7 b0960 2664 787 17 ccmD 2605 1083
8 yaiD 1 4284 18 agaA 885 2483
9 b1815 3178 43 19 ymcC 568 2587
10 ydaK 375 2548 20 abc 389 2705
The “*” gives the rank in the ethanol and non-ethanol signature in Rollins et al. [2].
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are beyond the scope of this work.
Skeletal Muscle Growth in Mice Study
The second study is a data set that involved the use of myostatin as inhibitor of skele-
tal muscle growth for five 5-week-old myostatin (called “mutant”) and non-treated
(called “wild-type”) mice in each group. A powerful method for ranking genes and
determining the size of signatures is the Q-method developed by Storey and Tibshirani
[12]. The Q-method uses Tpooled and a novel method for achieving high SP and low
FDR. The Q-method first uses Tpooled to obtain p-values then convert to q-values to
determine where to cut-off signatures based on a maximum q-value. Given that the q-
value is related to the p-value, one could also rank genes based on p-values or their
Tpooled values which are inversely related. Since we are primarily interested in ranking
genes in this work, we will compare the techniques based on the abilities of Tpooled and
the PM to find top ranked genes.
PCA results for PM are given in Figure 4. These results were obtained from the first
PC for an EA analysis (since it indicated the strongest separation) using Tdiff
EA
i1 only to
Figure 3 EA1 Score plot (a) and gene signature plot (b) for the E. coli in ethanol and non-ethanol
study. The score plot shows excellent separation for the non-ethanol group (A) and ethanol group (B). For
the signature plot on the right, the rank decreases as the number increases. The top ranking genes seen
on the upper left in plot (b) shows distinct separation as an evidence of the vertical line gap between the
genes.
Figure 4 EA1 Score plot (a) and gene signature plot (b) for the skeletal muscle growth in mice
study. The score plot shows excellent grouping for the mutant mice (A) and the wild-type mice (B) assays.
For the signature plot on the right, the rank decreases as the number increases. The top ranking genes
seen in plot (b) show distinct separation by how they line up almost vertically along the vertical axis
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4, because it separated the two groups in the score plot quite well. As shown by the
Tdiff
EA
i1 plot on the right, the top genes clearly standout by their distinct separation and
by how they line up along the vertical axis. The top genes that the PM identified were
genes identified in Steelman et al. [10]. In addition, it also identified genes that were
not previously identified in their work.
A comparison of the PM and the CM is given in Table 2. In this table, the top 200
genes of the CM are selected as the base set. The number and percentage of the top
1 0 ,2 0 ,... ,1 0 0g e n e so ft h eP Mi nt h i ss e ta r eg i v e n .F o ra ne x a m p l e ,i fo n ew i l lt o
compute the percentage of top 10 genes found using the PM in comparison to the 200
genes found using CM (base set). The computation can be done simply dividing the
number of genes in common between two groups by 10. This analysis is represented
by the first three columns in the table. In addition, this table gives results that switch
the roles of the PM and CM. More specifically, the top 200 genes of the PM are
selected as the base set and the number and percentage of the top 10, 20, . . ., 100
genes of the CM in this set are determined. This analysis is represented by the last
three columns in Table 2. With the CM as the base set, the results range from 70% of
the top 10 genes to 22% of the top 100 genes of the PM being in set of the top 200
genes of the CM. Similarly, with the PM as the base set, the results range from 50% of
the top 10 genes to 22% of the top 100 genes of the CM being in the set of the top
200 genes of the PM. Thus, while there is agreement between the two approaches, the
lack of agreement warrants further investigation on the best choice of method based
on the criteria of highest SP and lowest FDR. Our last study is a Monte Carlo simula-
tion data study to compare these two approaches under these criteria.
Simulation Study
As stated above, the purpose of the simulated data study is to evaluate and compare
the PM and CM to identify genes with significant differential effects. We simulated
several data sets based on the statistical properties of the data matrix from the second
study. More specifically, each data matrix contained 40,000 genes with 10 assays of five
Table 2 Top ranked genes of one method in the top 200 genes of the other method in
study (ii)
x x in top 200 CM
genes
%x in Top 200 CM
genes
y y in top 200 PM
genes
%y in Top 200 PM
genes
10 77 0 10 55 0
20 94 5 20 73 5
30 10 33 30 72 3
40 10 25 40 11 28
50 11 22 50 15 30
60 17 28 60 17 28
70 19 27 70 17 24
80 20 25 80 19 24
90 20 22 90 20 22
100 21 21 100 21 21
This table shows how many of the top genes for one method are in the top 200 genes of the other method with × = #
of top PM genes and y = # of top CM genes. For example, the result for × = 30 means that 10 (33%) of the top 30
genes of the PM where in the top 200 genes of the CM.
Rollins and Teh BioData Mining 2010, 3:11
http://www.biodatamining.org/content/3/1/11
Page 12 of 18samples in each group. The distribution for the simulated data can be described as
follows:
xN i j ij x x
indep
i j ~ ,, , 
2 () ∀ (24)
such that


x j
ij
otherwise
=
+> = … = ⎧
⎨
⎩
53
53
0 1 200 1 5 .,
.,
;, ,; , , 
(25)
Thus, 200 of the genes for each of the assays in Group A had the largest mean and
were significantly different than all the other genes that had a mean of 5.3. The study
will evaluate the ability of the CM and PM to identify these 200 genes when the var-
iance for all the data in the data matrix is the same (Part 1) and when the variance dif-
fers from gene to gene (Part 2). Each result in the simulation study is an average of
five trials. For simplicity, all the results in this study will be based on eigengene (EG)
principal components (PCs) as it gave strong separation of the groups.
Simulation Study – Part 1
In the first simulation study we evaluated the techniques under different levels of  x
2
with δ = 1. (Note that for, δ = 1, the value of sx is the same as the coefficient of varia-
tion defined as sx/δ.) There were seven levels of  x
2 that ranged from 0.04 to 1.0.
Thus, the range of the coefficient of variation was also 0.2 to 1.0. The PCA results for
one trial of the PM at the lowest level of  x
2 are given in Figure 5. As shown, the
loading plot indicates excellent separation of Group A and Group B indicating that
PCA was able to pick up a difference of δ =1q u i t ew e l lf o r2 0 0o ft h e4 0 , 0 0 0g e n e s
using the Tdiff
EA
i1 test statistic. The signature plot reveals a distinct signature for these
genes as evidenced by the large gap. For this case the percents of the 200 significantly
different genes (SDG) ranked in the top 200 by Tdiff
EA
i1 , Tscaled
EA
i1 and Tpooled
EA
i ,w e r e
100.0%, 99.9% and 90.9%, respectively. These percentages for all the cases for this part
of the simulation study for these three test statistics are given in Figure 6. In addition,
this figure gives results for percentages of the SDG in the top 300 and top 400 for
Figure 5 Plot of Loading 1(a) and gene signature (b) when δ =1a n ds = 0.20. Plot (a) shows a
clean separation of Group A from Group B. Plot (b) shows the nice assay-specific gene signature
plotted against their rank.
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EG has the best performance, followed closely by Tdiff
EG
at the extremes and poorly by CM statistic Tpooled. Thus, when the variability of the
assays is similar, Tdiff
EG appears to be the best choice for identifying the most significant
genes.
Simulation Study – Part 2
In the second simulation study we evaluated the techniques by varying levels of  xi
2
for each gene and two levels of δ: 1 and 3. More specifically, the distribution for  xi
was log normal with mean 0.37 and variance 0.37
2. Thus, for each data table a  xi
was randomly generated for each gene i, i = 1, ..., m, and then ten simulated expression
values, one for each assay, were generated according to Eqs. 24 and 25 for the given
level of δ.
Identification results for this part of the study are given in Figure 7 as the percent of
the SDG that are in the top 200 and top 400 ranks determined by the three test statis-
tics. The best performing method this time is Tscaled
EG ,f o l l o w e db yTpooled ,a n dt h e nb y
Tdiff
EG .A tδ = 3, all three methods are close but spread out at δ = 1. While the spread
Figure 6 Comparison of three test statistics in term of % of identified for simulation study. This plot
shows the percent of each method in accurately identified the 200 SDG. The plot of the left shows a
comparison between Tscaled
EG and Tpooled. While the plot of the right shows a comparison between Tdiff
EG
and Tscaled
EG .
Figure 7 The % of SDG in the top ranked genes for δ = 1 (left) and δ = 3 (right). This figure shows
percent of the 200 significantly different genes (SDG) that are in top 200, top 300, and top 400 selected at
two different values of δ for the Tdiff, Tscaled, Tpooled for Part 2 of the simulation study.
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EG and Tpooled is significant, the spread for Tpooled and Tdiff
EG is quite
large. Thus, Tdiff
EG does not appear to be the best choice when δ is small and there is
significant variation between the genes across the assays. Since Tscaled
EG consistently did
the best, when the gene variation is significant across the assays, it is our
recommendation.
Our final analysis in this study evaluated performance in signature size determina-
tion. The CM is the Q-method developed by Storey and Tibshirani [12] that uses the
p-values of the t-test (i.e., Tpooled) and cuts the list off at a maximum Q-value, com-
monly 0.05, the value used in this analysis. The PM is the Inflection Method (IM) that
is described in Rollins et al.[2] that cuts the list off at the greatest change in the signa-
ture plot of the ranked genes. The results are from Part 1 of the simulation study with
a constant  xi for all the genes in a data table.
The results of this analysis are given in Figure 8. The plot gives the signature size
(SS) (i.e., the number of genes in the signature) and the SDG against xi .S t a t i s t i c a l
Power (SP) is seen by the height of the SDG curve. As typical, SP, as indicated by this
line, decreases as  xi increases. Hence, the PM signature performance is seen to be
significantly better than the CM in terms of SP. An indication of the false discovery
rate (FDR) of the methods can be compared by the separation of their two lines in
Figure 8. These lines for the PM are very close except at the highest levels of xi . This
Figure 8 Signature Size (SS) performance for the CM and PM. The plot gives the signature sizes (i.e.,
number of genes the method determines as being significant) and the number of the 200 significantly
different genes (SDG) in the signatures for the CM and PM. Higher statistical power (SP) is observed by the
higher height of the SDG plot and the higher false discovery rate (FDR) is observed by the greater
separation of the lines of the same color.
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small and hence, has a small FDR. The FDR of the CM appears to be much higher for
low values  xi and the SS drops to zero relatively quite fast so that performance at
low  xi is not too meaningful since there are very few genes in the signature. Thus,
the IM with the test statistics of the PM for determining signature cutoffs appears to
have merit as a viable approach.
Conclusion
This work proposed a new principal component analysis (PCA) method for analyzing
large dimensional data set such as gene expressions data set. The strength of the pro-
posed method (PM) comes from its data driven nature. It is data driven because the
relationships obtained by PCA are only determined by those that exist in the data.
Thus, no predetermined grouping or any á priori knowledge has influence on the prin-
cipal components (PCs) obtained. After obtaining the PCs, they are used to match and
verify the existence of the assay groups of interests. From the PCs that have the stron-
gest match, the contribution of each gene providing the greatest differential expres-
sions are identified and ranked. Thus, a PM signature is not just a difference of
expression levels for genes but differences in a direction verified to have the character-
istics of interests. This approach distinguishes PM from methods that do not form
groups on the basis of data analysis and develop signatures from the differences
between two groups in the original data space. One should be cautioned that as the
number of members in the groups becomes smaller, the probability a particular order
of the assays increases. Thus, for a small number of assays, one should require greater
separation of groups for high confidence in the true existence of the groups.
Following Rollins et al. [2], the PM develops test statistics treating the assays as vari-
ables (eigengenes, EG) and the genes as variables (eigenassays, EA). These test statistics
are linear combinations of these variables (i.e., pseudo variables) as determined from
the elements of the eigenvectors. One test statistic, called Tdiff is the difference of the
average expression levels between two groups of pseudo variables. The other test sta-
tistics, called Tscaled,i sTdiff divided by the estimated pooled standard deviation. We
compared the performance of these two test statistics with the common and popular
Student’s t-statistic, Tpooled that we called the current method (CM). Two real data stu-
dies provided evidence in support of the PM as a viable technique. A simulation study
provided the strongest supportive evidence for the use of Tdiff when the gene variability
is fairly uniform throughout a data table and for Tscaled when the variability is not fairly
uniform. However, one should note that this study was done under a particular set of
model assumptions. The most critical one is independence. If the data have a particu-
lar correlation structure, which is not uncommon given that all the genes in an assay
experience the same set of conditions, the results in this article may not be supported.
Future work will include evaluating the PM under the kinds of correlation structures
found in real expression data. Finally, with the PM test statistics, the inflection method
(IM) introduced by Rollins et al. [2], indicated strong promise in determining signature
cutoffs in terms of statistical power and false discovery rate (FDR) as compared to CM.
We are applying the PM in a variety of applications involving biological as well as
physical phenomenon, with promising results. These applications include: 1. Nitric
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Page 16 of 18Oxide- and S-nitrosoglutathione-responsive genes in E-coli; 2. analysis of DNA micro-
array data for juvenile small round blue cell tumors; 3. analysis of metabolite data
from corn tissues (silk, pollen, coleoptile, and seedlings) for differential expression
levels between the wild type and genetic mutations; 4. analysis of spectroscopy data for
super alloys; and 5. the enhancement of nondestructive tests for ceramic armor in the
resistance of ballistic penetration. Thus, the PM has potential application in a variety
of situations where differential analysis is needed on large data sets with a relatively
small number of different conditions or assays. It appears to have promise for these
applications for high SP and low FDR as compared to other currently available
methods.
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